Jonette Keri is a Dermatology physician affiliated with University of Miami. OpenAlex indexes 97 publications with 3,894 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 NW 10th Ave
Room 2023a (r-250)
Miami, FL 331361015
Telephone
305-243-4472Registry record last updated 13 Feb 2015.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20251 payment
- Organon LLCProgram year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
53.3%Tetracycline-class Drug28.3%Doxycycline Hyclate100%Part D<11 patientsAzole Antifungal25%Ketoconazole100%Part D<11 patientsDermatology
30.4%Other antifungals for topical use16.3%Ciclopirox100%Part D<11 patientsCorticosteroid14.1%Triamcinolone Acetonide100%Part D≥12 patientsRespiratory
16.3%RNA Synthetase Inhibitor Antibacterial16.3%Mupirocin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Exploring the Potential Dermatological Benefits of CGRP Inhibition: A Case Report
Journal of Drugs in Dermatology
2025 - Guidelines of care for the management of acne vulgaris
Journal of the American Academy of Dermatology
2024 - Insights into acne and the skin barrier: Optimizing treatment regimens with ceramide‐containing skincare
Journal of Cosmetic Dermatology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carlos Singer
University of Miami
Jay Spiegel, MD
University of Miami
Kara Cavuoto, MD
University of Miami
Sixto Arias, MD
University of Miami
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”